Belite Bio Inc (BLTE)
Belite Bio Inc Statistics
Share Statistics
Belite Bio Inc has 31.83M shares outstanding. The number of shares has increased by 6.82% in one year.
| Shares Outstanding | 31.83M |
| Shares Change (YoY) | 6.82% |
| Shares Change (QoQ) | 3.07% |
| Owned by Institutions (%) | 0.92% |
| Shares Floating | 14.08M |
| Failed to Deliver (FTD) Shares | 165 |
| FTD / Avg. Volume | 0.39% |
Short Selling Information
The latest short interest is 69.99K, so 0.22% of the outstanding shares have been sold short.
| Short Interest | 69.99K |
| Short % of Shares Out | 0.22% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 2.39 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -37.65. Belite Bio Inc's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -37.65 |
| PS Ratio | 0 |
| Forward PS | 7.2 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Belite Bio Inc.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.31, with a Debt / Equity ratio of 0.
| Current Ratio | 24.31 |
| Quick Ratio | 24.31 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.27M |
| Employee Count | 25 |
| Asset Turnover | null |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 9K |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 63.24% in the last 52 weeks. The beta is -1.52, so Belite Bio Inc's price volatility has been lower than the market average.
| Beta | -1.52 |
| 52-Week Price Change | 63.24% |
| 50-Day Moving Average | 60.94 |
| 200-Day Moving Average | 58.26 |
| Relative Strength Index (RSI) | 39.21 |
| Average Volume (20 Days) | 42.45K |
Income Statement
| Revenue | n/a |
| Gross Profit | -399K |
| Operating Income | -31.67M |
| Net Income | -31.63M |
| EBITDA | -31.53M |
| EBIT | -31.67M |
| Earnings Per Share (EPS) | -1.19 |
Balance Sheet
The company has 31.68M in cash and 537K in debt, giving a net cash position of 31.14M.
| Cash & Cash Equivalents | 31.68M |
| Total Debt | 537K |
| Net Cash | 31.14M |
| Retained Earnings | -107.65M |
| Total Assets | 152.13M |
| Working Capital | 141.02M |
Cash Flow
In the last 12 months, operating cash flow was -29.23M and capital expenditures -151K, giving a free cash flow of -29.39M.
| Operating Cash Flow | -29.23M |
| Capital Expenditures | -151K |
| Free Cash Flow | -29.39M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BLTE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BLTE is $100, which is 77.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $100 |
| Price Target Difference | 77.1% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 174.05 |
| Piotroski F-Score | 1 |